US EditionAquestive Therapeutics announces pricing of $85 million underwritten offering of shares
Summary by ROI-NJ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Aquestive Therapeutics announces pricing of $85 million underwritten offering of shares
Pharmaceutical company Aquestive Therapeutics Inc. this week announced the pricing of an underwritten offering of 21,250,000 shares of its common stock at an offering price of $4 per share. The gross proceeds of the offering, before deducting the underwriting discounts and commissions and other offering expenses payable by Aquestive, are expected to be $85 million. The company intends to use the net proceeds along with the company’s cash and cas…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
